Stock 2361 SINOHEALTH HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Sinohealth Holdings Limited

Equities

2361

KYG8192Q1064

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:03 2024-05-23 am EDT 		5-day change 1st Jan Change
5.31 HKD -0.19% Intraday chart for Sinohealth Holdings Limited -0.19% -4.32%
Apr. 24 Sinohealth Holdings Profit Nearly Doubles in 2023 MT
Mar. 28 Sinohealth Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 25 September 2024 CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 48% by 2026.
  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • Most analysts recommend that the stock should be sold or reduced.
  • The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.

Ratings chart - Surperformance

Sector: Business Support Services

1st Jan change Capi. Investor Rating ESG Refinitiv
SINOHEALTH HOLDINGS LIMITED Stock Sinohealth Holdings Limited
-4.32% 283M -
CINTAS CORPORATION Stock Cintas Corporation
+16.45% 71.21B
B+
JACOBS SOLUTIONS INC. Stock Jacobs Solutions Inc.
+6.22% 17.26B
B+
RB GLOBAL, INC. Stock RB Global, Inc.
+13.63% 13.96B
B-
BUREAU VERITAS SA Stock Bureau Veritas SA
+21.47% 13.54B
A-
INTERTEK GROUP PLC Stock Intertek Group plc
+16.30% 10.13B
B-
TELEPERFORMANCE SE Stock Teleperformance SE
-18.33% 7.05B
C
GENPACT LIMITED Stock Genpact Limited
-1.24% 6.17B
A-
MAXIMUS, INC. Stock Maximus, Inc.
+2.30% 5.22B
B-
EXLSERVICE HOLDINGS, INC. Stock ExlService Holdings, Inc.
+1.00% 5.06B
A-
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
-
  1. Stock Market
  2. Equities
  3. 2361 Stock
  4. Ratings Sinohealth Holdings Limited